BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
CECR |
|
cat eye syndrome chromosome region
|
|
|
0.599 |
0.731 |
GCY |
|
growth control, Y chromosome influenced
|
|
|
0.631 |
0.615 |
GTS |
|
Gilles de la Tourette syndrome
|
|
|
0.682 |
0.615 |
IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
SAA3P |
|
serum amyloid A3, pseudogene
|
|
|
0.722 |
0.500 |
TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
LOH19CR1 |
|
loss of heterozygosity, 19, chromosomal region 1
|
|
|
0.569 |
0.808 |
DBA2 |
|
Diamond-Blackfan anemia 2
|
|
|
0.599 |
0.731 |
HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
PTPRVP |
|
protein tyrosine phosphatase receptor type V, pseudogene
|
|
|
0.705 |
0.577 |
DNAJB1P1 |
|
DnaJ heat shock protein family (Hsp40) member B1 pseudogene 1
|
|
|
0.650 |
0.654 |
COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
H3P44 |
|
H3 histone pseudogene 44
|
|
|
0.636 |
0.462 |
LINC01193 |
|
long intergenic non-protein coding RNA 1193
|
|
|
0.565 |
0.692 |
MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
MIRLET7B |
|
microRNA let-7b
|
|
|
0.493 |
0.769 |
MIR10A |
|
microRNA 10a
|
|
|
0.513 |
0.846 |
MIR140 |
|
microRNA 140
|
|
|
0.522 |
0.769 |
MIR142 |
|
microRNA 142
|
|
|
0.480 |
0.846 |
MIR143 |
|
microRNA 143
|
|
|
0.462 |
0.885 |